View source for Reduce cardiorenal chance together with sodiumglucose cotransporter2 inhibitors vs dipeptidyl peptidase4 inhibitors in people using type 2 diabetes with out aerobic as well as renal ailments A sizable worldwide observational study
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.